SphingoTec Employee Directory
Biotechnology ResearchBrandenburg, Germany11-50 Employees
SphingoTec GmbH is a biotechnology research company focused on developing biomarkers to assist diagnosis, prediction, and monitoring of acute medical conditions such as acute heart failure, acute kidney injury, and circulatory shock. Its work aims to support patient management and inform treatment decisions, while also pursuing biomarkers that help predict health risks like obesity, cardiovascular disease, and breast cancer for prevention purposes. The company operates in the biotechnology research sector and positions itself around real-time or timely assessment of medical states to guide clinical decision-making. It is based in Hennigsdorf, Brandenburg, Germany, and has been established in 2002. Recent activity includes the commercial introduction of the AFIAS sphingotest penKid assay, announced in 2025 in collaboration with Boditech Med Inc. } }{
1-888-653-2347 
support@leadiq.com 
